Dyne Therapeutics (DYN) Total Liabilities (2019 - 2026)

Dyne Therapeutics' Total Liabilities history runs 8 years deep, the most recent figure standing at $214.9 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 312.46% year-over-year to $214.9 million; the TTM figure through Mar 2026 stood at $214.9 million (up 312.46% YoY), while the FY2025 annual figure was $214.8 million, up 249.91% from the prior year.
• Total Liabilities was $214.9 million for Q1 2026 at Dyne Therapeutics, roughly flat from $214.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $214.9 million in Q1 2026 to a low of $44.2 million in Q1 2024.
• Historically, Total Liabilities has averaged $85.9 million across 5 years, with a median of $53.2 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Total Liabilities declined 16.8% in 2024, then jumped 312.46% in 2026.
• A 5-year view of Total Liabilities shows it stood at $54.0 million in 2022, then jumped by 36.75% to $73.8 million in 2023, then slipped by 16.8% to $61.4 million in 2024, then surged by 249.91% to $214.8 million in 2025, then rose by 0.03% to $214.9 million in 2026.
• The last three Total Liabilities figures came in at $214.9 million (Q1 2026), $214.8 million (Q4 2025), and $175.3 million (Q3 2025), per Business Quant data.